The Illinois Biotechnology Industry Organization (iBIO) and the iBIO Institute will launch a patient-focused center in the iBIO Institute in Chicago.
The new center will provide vital resources and connections between patient groups, clinical research institutions and the medical science industry. The national Biotechnology Innovation Organization (BIO) and Horizon Pharma will fund the center's launch.
The patient center initially will offer advocacy training, curriculum development and common best practices to help patient-centered organizations. Eventually, it will provide office amenities and connect patient organizations to their stakeholders.
“Horizon Pharma is committed to helping patients lead better lives through medical innovation,” Horizon Pharma Chairman, President and CEO Timothy Walbert said. “Strengthening the network between patient groups, researchers and industry will benefit clinical research and create an ecosystem that empowers patients to play a role in how their diseases will be treated in the future. This one-of-a-kind initiative allows iBIO and the institute to leverage the BIO, AdvaMed ( Advanced Medical Technology Association) and PhRMA (Pharmaceutical Research and Manufacturers of America) networks to highlight best practices and pool resources.”
The official launch of the patient center will be April 20 at the iBIO IndEx conference, the largest gathering of biotechnology professionals in Illinois, in Evanston.
“I am excited to launch the patient center initiative, and the iBIO IndEx is the perfect forum for its inaugural programming." iBIO and iBIO Institute President and CEO Warren Ribley said. "Our theme for the IndEx is Converge to Emerge, and this new patient center is a perfect example of how our community can come together to facilitate patient centered innovation. The seed funding from BIO and Horizon enabled us to host focus groups and establish the foundation to launch this patient initiative. I want to thank all of the organizations participating on the advisory board. Their insight and guidance will be critical to the development of the patient enter in the iBIO Institute.”